Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Update

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 4,900 shares, an increase of 122.7% from the September 30th total of 2,200 shares. Based on an average trading volume of 30,100 shares, the short-interest ratio is currently 0.2 days.

Invesco Nasdaq Biotechnology ETF Stock Performance

NASDAQ IBBQ traded down $0.01 during trading hours on Friday, hitting $23.48. The company had a trading volume of 1,387 shares, compared to its average volume of 20,266. The firm has a market capitalization of $38.27 million, a price-to-earnings ratio of 17.39 and a beta of 0.61. Invesco Nasdaq Biotechnology ETF has a 52 week low of $18.18 and a 52 week high of $24.84. The firm has a 50 day simple moving average of $23.98 and a 200 day simple moving average of $23.04.

Invesco Nasdaq Biotechnology ETF Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 27th. Shareholders of record on Monday, September 23rd were issued a $0.089 dividend. This represents a $0.36 annualized dividend and a yield of 1.52%. This is an increase from Invesco Nasdaq Biotechnology ETF’s previous quarterly dividend of $0.05. The ex-dividend date was Monday, September 23rd.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Lake Street Advisors Group LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF in the 1st quarter worth $286,000. Mirae Asset Global Investments Co. Ltd. grew its position in Invesco Nasdaq Biotechnology ETF by 22.7% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 259,733 shares of the company’s stock worth $6,156,000 after acquiring an additional 48,137 shares in the last quarter. Finally, ORG Partners LLC bought a new position in Invesco Nasdaq Biotechnology ETF in the third quarter valued at $25,000.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.